|
5-MTHF (nmol/L)
|
One-way ANOVA P
|
Two-way ANOVA P interaction
|
---|
CBMN markers
|
DEB (μmol/L)
|
3
|
30
|
300
|
---|
MN(‰)
|
0
|
7.00 ± 1.00
|
7.33 ± 1.528
|
4.00 ± 2.646
|
0.129
| |
10
|
21.67 ± 1.16aa
|
13.67 ± 2.31**
|
12.33 ± 1.16***aa
|
0.001
| |
20
|
31.00 ± 1.00aaabb
|
25.00 ± 1.00*aaabb
|
20.67 ± 4.51**aaabb
|
0.010
| |
40
|
59.33 ± 3.79aabc
|
35.67 ± 7.02**aaabbbcc
|
29.33 ± 1.53***aaabbbcc
|
< 0.001
| |
One-way ANOVA P
|
< 0.001
|
< 0.001
|
< 0.001
| |
< 0.001
|
NPB(‰)
|
0
|
4.00 ± 1.00
|
3.00 ± 1.00
|
1.33 ± 0.58*
|
0.027
| |
10
|
6.00 ± 1.00
|
5.33 ± 2.08
|
2.66 ± 1.53*
|
0.092
| |
20
|
12.67 ± 1.53aaabb
|
9.33 ± 1.53*aab
|
7.33 ± 1.53**aabb
|
0.014
| |
40
|
25.00 ± 2.65aaabbbccc
|
17.33 ± 1.53**aaabbbccc
|
12.00 ± 1.73***#aaabbbcc
|
< 0.001
| |
One-way ANOVA P
|
< 0.001
|
< 0.001
|
< 0.001
| |
< 0.001
|
NBUD(‰)
|
0
|
8.00 ± 1.00
|
6.67 ± 1.16
|
3.67 ± 0.58**##
|
0.004
| |
10
|
11.00 ± 1.00a
|
10.67 ± 2.08
|
7.33 ± 1.53*#aa
|
0.056
| |
20
|
13.33 ± 1.53aa
|
12.00 ± 2.646a
|
12.00 ± 1.00aaabb
|
0.621
| |
40
|
27.33 ± 1.53aaabbbccc
|
20.67 ± 2.52**aaabbbcc
|
15.67 ± 1.16***#aaabbbcc
|
< 0.001
| |
One-way ANOVA P
|
< 0.001
|
< 0.001
|
< 0.001
| |
< 0.001
|
- ANOVA, compared with 5-MTHF 3 nmol/L,*p < 0.05, **p < 0.01, ***p < 0.001; compared with 5-MTHF 30 nmol/L,#p < 0.05, ##p < 0.01, ###p < 0.001. Compared with DEB control (0 μmol/L), a, p < 0.05, aa, p < 0.01, aaa, p < 0.001; compared with DEB 10 μmol/L, b, p < 0.05, bb, p < 0.01, bbb, p < 0.001; compared with DEB 20 μmol/L, c, p < 0.05, cc, p < 0.01, ccc, p < 0.001